H.A. Katus
Derivation and validation of a simple clinical risk-model in heart failure based on 6 minute walk test performance and NT-proBNP status - Do we need specificity for sex and beta-blockers?
Katus, H.A.; Cleland, J.G.F.; Frankenstein, L.; Goode, K.; Clark, A.L.; Ingle, Lee; Ingle, Lee; Remppis, A.; Schellberg, D.; Nelles, M.; Katus, H. A.; Clark, A. L.; Cleland, J. G. F.; Zugck, C.
Authors
J.G.F. Cleland
L. Frankenstein
Dr Kevin Goode K.M.Goode@hull.ac.uk
Research Systems Project Manager / Business Analyst
A.L. Clark
Lee Ingle
Lee Ingle
A. Remppis
D. Schellberg
M. Nelles
H. A. Katus
A. L. Clark
J. G. F. Cleland
C. Zugck
Abstract
BACKGROUND It is unclear whether risk prediction strategies in chronic heart failure (CHF) need to be specific for sex or beta-blockers. We examined this problem and developed and validated the consequent risk models based on 6-minute-walk-test and NT-proBNP. METHODS The derivation cohort comprised 636 German patients with systolic dysfunction. They were validated against 676 British patients with similar aetiology. ROC-curves for 1-year mortality identified cut-off values separately for specificity (none, sex, beta-blocker, both). Patients were grouped according to number of cut-offs met (group I/II/III - 0/1/2 cut-offs). RESULTS Widest separation between groups was achieved with sex- and beta-blocker-specific cut offs. In the derivation population, 1-year mortality was 0%, 8%, 31% for group I, II and III, respectively. In the validation population, 1-year rates in the three risk groups were 2%, 7%, 14%, respectively, after application of the same cut-offs. CONCLUSION Risk stratification for CHF should perhaps take sex and beta-blocker usage into account. We derived and independently validated relevant risk models based on 6-minute-walk-tests and NT-proBNP. Specifying sex and use of beta-blockers identified three distinct sub-groups with widely differing prognosis. In clinical practice, it may be appropriate to tailor the intensity of follow-up and/or the treatment strategy according to the risk-group.
Citation
Frankenstein, L., Goode, K., Ingle, L., Remppis, A., Schellberg, D., Nelles, M., Katus, H. A., Clark, A. L., Cleland, J. G. F., & Zugck, C. (2011). Derivation and validation of a simple clinical risk-model in heart failure based on 6 minute walk test performance and NT-proBNP status - Do we need specificity for sex and beta-blockers?. International journal of cardiology, 147(1), 74-78. https://doi.org/10.1016/j.ijcard.2009.08.005
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 11, 2009 |
Online Publication Date | Sep 7, 2009 |
Publication Date | Feb 17, 2011 |
Journal | International journal of cardiology |
Print ISSN | 0167-5273 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 147 |
Issue | 1 |
Pages | 74-78 |
DOI | https://doi.org/10.1016/j.ijcard.2009.08.005 |
Keywords | Chronic heart failure; Risk prediction; Beta-blockers; Sex |
Public URL | https://hull-repository.worktribe.com/output/423648 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S0167527309008547?via%3Dihub |
PMID | 19765836 |
You might also like
Metabolic remodeling in the aging heart
(2005)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search